Third-Party Review Could Help Revive OTC Monograph Process, Attorney Says
This article was originally published in The Tan Sheet
Executive Summary
Outside party review of OTC drugs for monograph approval could help renew an industry that is "stagnating," Akin, Gump, Strauss, Hauer & Feld attorney Robert Pinco suggested at a Drug Information Association conference on "OTCness" in Washington, D.C. Sept. 16-17.